NCT04954651已完成不适用
Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received European Union (EU) -Approved COVID-19 Vaccines
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Antibody titer against Sars-Cov2
研究概览
简要总结
Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects who voluntarily receive COVID-19 vaccination
排除标准
- •Patients who do not complete their vaccination
- •Patients who do not provide info on their health status
结局指标
主要结局
Antibody titer against Sars-Cov2
时间窗: 0-9 months
次要结局
未报告次要终点
研究者
Ioannis Habeos
Professor
University of Patras
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Volunteer Screening for Vaccine and Antivirals Clinical TrialsNormal PhysiologyNCT01593709National Institute of Allergy and Infectious Diseases (NIAID)359
Unknown
不适用
COVID-19 Vaccine Effectiveness Among Health Workers in GeorgiaCovid19NCT04868448National Center for Disease control and Public Health1,600
已完成
4 期
SARS-CoV-2 vaccination response in patients with haematological diseaseNL-OMON52047Medisch Universitair Ziekenhuis Maastricht160
Unknown
不适用
Evolution of Protective Immunization Against COVID-19 Among Hospital Workers in Health Care FacilitiesCovid19NCT05011344Assistance Publique Hopitaux De Marseille1,000
已完成
不适用
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral ProductsVaccinesAntiviral AgentsImmunologic FactorsPhysiological Effects of DrugsAnti-Infective AgentsNCT02242968National Institute of Allergy and Infectious Diseases (NIAID)9